Key Findings:  In conclusion, the low concentration of BCP has higher selective anti-inflammatory effects rather than high levels. On this occasion, BCP by modulating the microglia is able to have potential therapeutic effects in neuro-inflammation conditions and microglia cells such as MS and AD.
Type of Study:  Laboratory Study
Study Result:  Positive
Study Location(s):  Iran
Year of Pub:  2018
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2, PPAR - Gamma
Ligands Studied:  Anti-inflammatory cytokines, Pro-inflammatory cytokines